Literature DB >> 23528916

Consensus on current management of endometriosis.

Neil P Johnson1, Lone Hummelshoj.   

Abstract

STUDY QUESTION: Is there a global consensus on the management of endometriosis that considers the views of women with endometriosis? SUMMARY ANSWER: It was possible to produce an international consensus statement on the current management of endometriosis through engagement of representatives of national and international, medical and non-medical societies with an interest in endometriosis. WHAT IS KNOWN ALREADY: Management of endometriosis anywhere in the world has been based partially on evidence-based practices and partially on unsubstantiated therapies and approaches. Several guidelines have been developed by a number of national and international bodies, yet areas of controversy and uncertainty remain, not least due to a paucity of firm evidence. STUDY DESIGN, SIZE, DURATION: A consensus meeting, in conjunction with a pre- and post-meeting process, was undertaken. PARTICIPANTS/MATERIALS, SETTING,
METHODS: A consensus meeting was held on 8 September 2011, in conjunction with the 11th World Congress on Endometriosis in Montpellier, France. A rigorous pre- and post-meeting process, involving 56 representatives of 34 national and international, medical and non-medical organizations from a range of disciplines, led to this consensus statement. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 69 consensus statements were developed. Seven statements had unanimous consensus; however, none of the statements were made without expression of a caveat about the strength of the statement or the statement itself. Only two statements failed to achieve majority consensus. The statements covered global considerations, the role of endometriosis organizations, support groups, centres or networks of expertise, the impact of endometriosis throughout a woman's life course, and a full range of treatment options for pain, infertility and other symptoms related to endometriosis. LIMITATIONS, REASONS FOR CAUTION: This consensus process differed from that of formal guideline development. A different group of international experts from those participating in this process would likely have yielded subtly different consensus statements. WIDER IMPLICATIONS OF THE
FINDINGS: This is the first time that a large, global, consortium, representing 34 major stake-holding organizations from five continents, has convened to systematically evaluate the best available current evidence on the management of endometriosis, and to reach consensus. In addition to 18 international medical organizations, representatives from 16 national endometriosis organizations were involved, including lay support groups, thus generating input from women who suffer from endometriosis.

Entities:  

Keywords:  WES Montpellier Consortium; World Endometriosis Society; endometriosis; evidence based; management

Mesh:

Year:  2013        PMID: 23528916     DOI: 10.1093/humrep/det050

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  109 in total

1.  Endometriosis - A Chameleon: Patients' Perception of Clinical Symptoms, Treatment Strategies and Their Impact on Symptoms.

Authors:  P Wimberger; N Grübling; A Riehn; M Furch; J Klengel; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

Review 2.  Endometriosis and nuclear receptors.

Authors:  Bahar D Yilmaz; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2019-07-01       Impact factor: 15.610

Review 3.  Endometriosis-associated Clear Cell Carcinoma of the Abdominal Wall After Caesarean Section: A Case Report and Review of the Literature.

Authors:  Luca Giannella; Matteo Serri; Elena Maccaroni; Jacopo DI Giuseppe; Giovanni Delli Carpini; Rossana Berardi; Francesco Sopracordevole; Andrea Ciavattini
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 4.  Imaging modalities for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Cindy Farquhar; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

5.  Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study.

Authors:  T Kacan; C Yildiz; S Baloglu Kacan; M Seker; H Ozer; A Cetin
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-01       Impact factor: 2.915

Review 6.  Diagnosing endometriosis in primary care: clinical update.

Authors:  Jennifer L Johnston; Helen Reid; David Hunter
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

7.  Coping strategies employed by women with endometriosis in a public health-care setting.

Authors:  Rizwana Roomaney; Ashraf Kagee
Journal:  J Health Psychol       Date:  2015-03-13

8.  ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis.

Authors:  D Monsivais; M T Dyson; P Yin; J S Coon; A Navarro; G Feng; S S Malpani; M Ono; C M Ercan; J J Wei; M E Pavone; E Su; S E Bulun
Journal:  Mol Endocrinol       Date:  2014-07-03

Review 9.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

Review 10.  Endometriosis: pathogenesis and treatment.

Authors:  Paolo Vercellini; Paola Viganò; Edgardo Somigliana; Luigi Fedele
Journal:  Nat Rev Endocrinol       Date:  2013-12-24       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.